Foundation news
CHOP’s Buddy Walk Raises Record-breaking Funds
CHOP’s 17th Annual Buddy Walk® & Family Fun Day raises a record-breaking $281,000 and counting for Children’s Hospital’s Trisomy 21 Program.
No More Kids with Cancer Awards $220,000 to CHOP
The $220,000 award will be directed to a Phase I clinical trial that will investigate the effectiveness of CAR T-cell therapy to treat AML.
2018 Parkway Run & Walk Raises Record-breaking $1.38 Million
Proceeds from the event will support breakthroughs in pediatric cancer research and care at Children's Hospital of Philadelphia.
Hyundai Hope on Wheels Presents CHOP with $500,000 Grant
Hyundai Hope on Wheels Awards CHOP with Hyundai Hope Scholar and Young Investigator Grant to support pediatric cancer research.
National Institutes of Health Names CHOP, Penn an Undiagnosed Diseases Network Site
The $2.5 million in research grants will allow both hospitals to work together to investigate diseases that have not yet been discovered.
Pioneers in Hyperinsulinism: Yesterday, Today and Tomorrow
CHOP’s groundbreaking expertise in treating children with congenital hyperinsulinism (HI) began more than 50 years ago and draws patients from all over the world.
How the NFL Is Informing Care for Kids
CHOP researchers will take data gleaned from helping pro athletes avoid head injuries to improve prevention, diagnosis and treatment of concussions in kids.
CBS3 Features CHOP Patient Kissed by Pope
CHOP patient family credits faith and doctors for recovery and donates $50,000 to Children's Hospital of Philadelphia.
Parents Magazine Names Children’s Hospital of Philadelphia Among 20 Most Innovative Children’s Hospitals
Children’s Hospital of Philadelphia was recognized specifically for significant contributions to the development of a new treatment for a certain pediatric leukemia.
CHOP President and CEO Madeline Bell Highlights Breakthroughs in New Podcast
Listen to Breaking Through with Madeline Bell for behind-the-scenes insights into some of CHOP’s most amazing discoveries. Hosted by Madeline Bell, President and CEO.